Effect of the Ductal Carcinoma In Situ Margin Consensus Guideline Implementation on Re-Excision Rates, Satisfaction, and Cost.
Journal
Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
received:
15
10
2020
accepted:
18
04
2021
pubmed:
28
5
2021
medline:
21
10
2021
entrez:
27
5
2021
Statut:
ppublish
Résumé
The 2016 consensus guideline on margins for breast-conserving surgery (BCS) with whole-breast irradiation (WBI) for ductal carcinoma in situ (DCIS) recommended 2 mm margins to decrease local recurrence rates. We examined re-excision rates, cost, and patient satisfaction before and after guideline implementation. From an Institutional Review Board-approved database, patients with DCIS who underwent BCS with over 1 year of follow-up at one academic institution and one community cancer center were evaluated. Two groups were compared based on when they received treatment, i.e. before (pre-consensus [PRE]) and after November 2016 (post consensus [POST]), with respect to outcome and cost parameters. After consensus guideline implementation, re-excision rate (32.1% vs. 20.0%) and mastectomy conversion (8.3% vs. 2.3%) significantly increased, although total resection volume, operative cost per patient, and satisfaction with breast scores did not differ. Not all patients with <2 mm margins were re-excised, although the re-excision rate among this subset significantly increased (62.4% vs. 31.3%). On multivariable analysis controlling for age, estrogen receptor status, WBI use, and margin status, surgery after consensus guideline publication was independently associated with a higher re-excision rate (odds ratio [OR] 1.97, 95% confidence interval [CI] 1.08-3.59, p = 0.03) and a higher rate of conversion to mastectomy (OR 6.84, 95% CI 1.67-28.00, p = 0.007). Implementation of the 2016 margin consensus guideline for DCIS resulted in an increase in re-excisions and mastectomy conversions at two institutions. Research is needed for operative tools and strategies to decrease DCIS re-excision rates.
Identifiants
pubmed: 34043091
doi: 10.1245/s10434-021-10120-z
pii: 10.1245/s10434-021-10120-z
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7432-7438Informations de copyright
© 2021. Society of Surgical Oncology.
Références
Moran MS, Schnitt SJ, Giuliano AE, et al. Society of surgical oncology-American society for radiation oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer. Int J Radiat Oncol Biol Phys. 2014;88:553–64.
doi: 10.1016/j.ijrobp.2013.11.012
Morrow M, Van Zee KJ, Solin LJ, et al. Society of surgical oncology-American society for radiation oncology-American society of clinical oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ. Pract Radiat Oncol. 2016;6:287–95.
doi: 10.1016/j.prro.2016.06.011
Havel L, Naik H, Ramirez L, Morrow M, Landercasper J. Impact of the SSO-ASTRO margin guideline on rates of re-excision after lumpectomy for breast cancer: a meta-analysis. Ann Surg Oncol. 2019;26:1238–44.
doi: 10.1245/s10434-019-07247-5
Bhutiani N, Mercer MK, Bachman KC, et al. Evaluating the effect of margin consensus guideline publication on operative patterns and financial impact of breast cancer operation. J Am Coll Surg. 2018;227:6–11.
doi: 10.1016/j.jamcollsurg.2018.01.050
Langhans L, Jensen M-B, Talman M-LM, Vejborg I, Kroman N, Tvedskov TF. Reoperation rates in ductal carcinoma in situ vs invasive breast cancer after wire-guided breast-conserving surgery. JAMA Surg. 2017;152:378–84.
doi: 10.1001/jamasurg.2016.4751
Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009;124:345–53.
doi: 10.1097/PRS.0b013e3181aee807
Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P. Breast cancer mortality after a diagnosis of ductal carcinoma in situ. JAMA Oncol. 2015;1:888–96.
doi: 10.1001/jamaoncol.2015.2510
Marinovich ML, Azizi L, Macaskill P, et al. The association of surgical margins and local recurrence in women with ductal carcinoma in situ treated with breast-conserving therapy: a meta-analysis. Ann Surg Oncol. 2016;23:3811–21.
doi: 10.1245/s10434-016-5446-2
DeSnyder SM, Hunt KK, Dong W, et al. American society of breast surgeons’ practice patterns after publication of the SSO-ASTRO-ASCO DCIS consensus guideline on margins for breast-conserving surgery with whole-breast irradiation. Ann Surg Oncol. 2018;25:2965–74.
doi: 10.1245/s10434-018-6580-9
Romanoff, A., Zabor, E., Stempel, M., Morrow, M., and Gemignani, M. L. Effect on re-excision rates after adoption of SSO-ASTRO-ASCO ductal carcinoma in situ (DCIS) margin consensus guidelines. Ann Surg Oncol. 2018:S108
Merrill AL, Tang R, Plichta JK, et al. Should new “No Ink On Tumor” lumpectomy margin guidelines be applied to ductal carcinoma in situ (DCIS)? A retrospective review using shaved cavity margins. Ann Surg Oncol. 2016;23:3453–8.
doi: 10.1245/s10434-016-5251-y
Subhedar P, Olcese C, Patil S, Morrow M, Van Zee KJ. Decreasing recurrence rates for ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery over 30 years. Ann Surg Oncol. 2015;22:3273–81.
doi: 10.1245/s10434-015-4740-8
Garg PK, Jakhetiya A, Pandey R, Chishi N, Pandey D. Adjuvant radiotherapy versus observation following lumpectomy in ductal carcinoma in-situ: a meta-analysis of randomized controlled trials. Breast J. 2018;24:233–9.
doi: 10.1111/tbj.12889
Solin LJ, Gray R, Hughes LL, et al. Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 2015;33:3938–44.
doi: 10.1200/JCO.2015.60.8588
Van Zee KJ, Subhedar P, Olcese C, Patil S, Morrow M. Relationship between margin width and recurrence of ductal carcinoma in situ: analysis of 2996 women treated with breast-conserving surgery for 30 years. Ann Surg. 2015;262:623–31.
doi: 10.1097/SLA.0000000000001454
Tadros AB, Smith BD, Shen Y, et al. Ductal carcinoma in situ and margins <2 mm: contemporary outcomes with breast conservation. Ann Surg. 2019;269:150–7.
doi: 10.1097/SLA.0000000000002439
Bhutiani N, Vuong B, Egger ME, Eldredge-Hindy H, McMasters KM, Ajkay N. Evaluating patterns of utilization of gene signature panels and impact on treatment patterns in patients with ductal carcinoma in situ of the breast. Surgery. 2019;166:509–14.
doi: 10.1016/j.surg.2019.04.044
Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004;10:223–31.
doi: 10.1111/j.1075-122X.2004.21323.x
Chagpar AB, Killelea BK, Tsangaris TN, et al. A randomized, controlled trial of cavity shave margins in breast cancer. N Engl J Med. 2015;373:503–10.
doi: 10.1056/NEJMoa1504473
Dupont E, Tsangaris T, Garcia-Cantu C, et al. Resection of cavity shave margins in stage 0-III breast cancer patients undergoing breast conserving surgery: a prospective multicenter randomized controlled trial. Ann Surg. 2021;273(5):876–81.
doi: 10.1097/SLA.0000000000003449
Cabioglu N, Hunt KK, Sahin AA, et al. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Ann Surg Oncol. 2007;14:1458–71.
doi: 10.1245/s10434-006-9236-0
Laws A, Brar MS, Bouchard-Fortier A, Leong B, Quan ML. Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ. J Surg Oncol. 2018;118:1205–11.
doi: 10.1002/jso.25248
Bruenderman EH, Bhutiani N, Mercer MK, McMasters KM, Sanders MAG, Ajkay NL. Evaluating the relationship between ductal carcinoma in situ, calcifications, and margin status in patients undergoing breast conserving surgery. J Surg Oncol. 2019;119:694–9.
doi: 10.1002/jso.25388
Lange M, Reimer T, Hartmann S, Glass A, Stachs A. The role of specimen radiography in breast-conserving therapy of ductal carcinoma in situ. Breast. 2016;26:73–9.
doi: 10.1016/j.breast.2015.12.014
St John ER, Al-Khudairi R, Ashrafian H, et al. Diagnostic accuracy of intraoperative techniques for margin assessment in breast cancer surgery: a meta-analysis. Ann Surg. 2017;265:300–10.
doi: 10.1097/SLA.0000000000001897
Wilson KE, Bachawal SV, Willmann JK. Intraoperative resection guidance with photoacoustic and fluorescence molecular imaging using an Anti-B7-H3 antibody-indocyanine green dual contrast agent. Clin Cancer Res. 2018;24:3572–82.
doi: 10.1158/1078-0432.CCR-18-0417